{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T22:13:39Z","timestamp":1783635219722,"version":"3.55.0"},"reference-count":133,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Virology"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.coviro.2019.06.004","type":"journal-article","created":{"date-parts":[[2019,8,3]],"date-time":"2019-08-03T23:00:31Z","timestamp":1564873231000},"page":"54-62","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["HIV-1 persistence in the central nervous system: viral and host determinants during antiretroviral therapy"],"prefix":"10.1016","volume":"38","author":[{"given":"EF","family":"Balcom","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"WC","family":"Roda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"EA","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MY","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Power","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coviro.2019.06.004_bib0005","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/S0140-6736(13)61809-7","article-title":"The end of AIDS: HIV infection as a chronic disease","volume":"382","author":"Deeks","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.coviro.2019.06.004_bib0010","doi-asserted-by":"crossref","first-page":"674","DOI":"10.7326\/M18-0759","article-title":"Mechanisms that contribute to a profound reduction of the HIV-1 reservoir after allogeneic stem cell transplant","volume":"169","author":"Salgado","year":"2018","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.coviro.2019.06.004_bib0015","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/s41586-019-1027-4","article-title":"HIV-1 remission following CCR5\u039432\/\u039432 haematopoietic stem-cell transplantation","volume":"568","author":"Gupta","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.coviro.2019.06.004_bib0020","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1097\/QAI.0b013e31827f1bdb","article-title":"Neurovirological correlation with HIV-associated neurocognitive disorders and encephalitis in a HAART-era cohort","volume":"62","author":"Gelman","year":"2013","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.coviro.2019.06.004_bib0025","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/cid\/ciu862","article-title":"Neurocognitive change in the era of HIV combination antiretroviral therapy: the longitudinal CHARTER study","volume":"60","author":"Heaton","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.coviro.2019.06.004_bib0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005153","article-title":"Adipose tissue is a neglected viral reservoir and an inflammatory site during chronic HIV and SIV infection","volume":"11","author":"Damouche","year":"2015","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2019.06.004_bib0035","first-page":"329","article-title":"Direct detection of HIV-1 RNA in epidermal Langerhans cells of HIV-infected patients","volume":"6","author":"Giannetti","year":"1993","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.coviro.2019.06.004_bib0040","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.3851\/IMP1919","article-title":"Pharmacokinetics of antiretroviral drugs in anatomical sanctuary sites: the male and female genital tract","volume":"16","author":"Else","year":"2011","journal-title":"Antivir Ther"},{"key":"10.1016\/j.coviro.2019.06.004_bib0045","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/s41564-018-0335-z","article-title":"HIV-1 reservoirs in urethral macrophages of patients under suppressive antiretroviral therapy","volume":"4","author":"Ganor","year":"2019","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.coviro.2019.06.004_bib0050","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1128\/JVI.76.7.3114-3124.2002","article-title":"A human immunodeficiency virus type 1 isolate from an infected person homozygous for CCR5Delta32 exhibits dual tropism by infecting macrophages and MT2 cells via CXCR4","volume":"76","author":"Naif","year":"2002","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2019.06.004_bib0055","doi-asserted-by":"crossref","first-page":"9307","DOI":"10.1128\/JVI.72.11.9307-9312.1998","article-title":"Chemokine coreceptor usage by diverse primary isolates of human immunodeficiency virus type 1","volume":"72","author":"Zhang","year":"1998","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2019.06.004_bib0060","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1007\/s13365-014-0287-x","article-title":"HIV-1 target cells in the CNS","volume":"21","author":"Joseph","year":"2015","journal-title":"J Neurovirol"},{"key":"10.1016\/j.coviro.2019.06.004_bib0065","doi-asserted-by":"crossref","first-page":"5430","DOI":"10.1128\/JVI.02648-08","article-title":"Tissue-specific sequence alterations in the human immunodeficiency virus type 1 envelope favoring CCR5 usage contribute to persistence of dual-tropic virus in the brain","volume":"83","author":"Gray","year":"2009","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2019.06.004_bib0070","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/1742-4690-9-82","article-title":"Macrophages and their relevance in human immunodeficiency virus type I infection","volume":"9","author":"Koppensteiner","year":"2012","journal-title":"Retrovirology"},{"key":"10.1016\/j.coviro.2019.06.004_bib0075","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/jnr.10762","article-title":"HIV-1 tat protein alters tight junction protein expression and distribution in cultured brain endothelial cells","volume":"74","author":"Andr\u00e1s","year":"2003","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.coviro.2019.06.004_bib0080","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.meegid.2014.07.022","article-title":"In-silico analysis of claudin-5 reveals novel putative sites for post-translational modifications: insights into potential molecular determinants of blood-brain barrier breach during HIV-1 infiltration","volume":"27","author":"Awan","year":"2014","journal-title":"Infect Genet Evol"},{"key":"10.1016\/j.coviro.2019.06.004_bib0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0175899","article-title":"Sensitive quantification of the HIV-1 reservoir in gut-associated lymphoid tissue","volume":"12","author":"Mor\u00f3n-L\u00f3pez","year":"2017","journal-title":"PLoS One"},{"issue":"Suppl._3","key":"10.1016\/j.coviro.2019.06.004_bib0090","doi-asserted-by":"crossref","first-page":"S134","DOI":"10.1093\/infdis\/jiw648","article-title":"Measuring the size of the latent human immunodeficiency virus reservoir: the present and future of evaluating eradication strategies","volume":"215","author":"Henrich","year":"2017","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coviro.2019.06.004_bib0095","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1750-3639.2003.tb00010.x","article-title":"HIV-1 persistence, viral reservoir, and the central nervous system in the HAART era","volume":"13","author":"Lambotte","year":"2003","journal-title":"Brain Pathol"},{"key":"10.1016\/j.coviro.2019.06.004_bib0100","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/01.wco.0000236614.51592.ca","article-title":"Influence of highly active antiretroviral therapy on persistence of HIV in the central nervous system","volume":"19","author":"Nath","year":"2006","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.coviro.2019.06.004_bib0105","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1128\/JVI.01863-09","article-title":"Compartmentalization and clonal amplification of HIV-1 variants in the cerebrospinal fluid during primary infection","volume":"84","author":"Schnell","year":"2010","journal-title":"J Virol"},{"issue":"20","key":"10.1016\/j.coviro.2019.06.004_bib0110","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00755-17","article-title":"Identification of emerging macrophage-tropic HIV-1 R5 variants in brain tissue of AIDS patients without severe neurological complications","volume":"91","author":"Gonzalez-Perez","year":"2017","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2019.06.004_bib0115","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/j.ajpath.2011.06.039","article-title":"Brain cell reservoirs of latent virus in presymptomatic HIV-infected individuals","volume":"179","author":"Thompson","year":"2011","journal-title":"Am J Pathol"},{"key":"10.1016\/j.coviro.2019.06.004_bib0120","doi-asserted-by":"crossref","first-page":"880","DOI":"10.7326\/0003-4819-103-6-880","article-title":"Primary human T-lymphotropic virus type III infection","volume":"103","author":"Ho","year":"1985","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.coviro.2019.06.004_bib0125","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/BF00315340","article-title":"Acute ataxia coincident with seroconversion for anti-HIV","volume":"238","author":"Scarpini","year":"1991","journal-title":"J Neurol"},{"key":"10.1016\/j.coviro.2019.06.004_bib0130","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1212\/WNL.42.9.1736","article-title":"Early viral brain invasion in iatrogenic human immunodeficiency virus infection","volume":"42","author":"Davis","year":"1992","journal-title":"Neurology"},{"key":"10.1016\/j.coviro.2019.06.004_bib0135","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/infdis\/jis326","article-title":"Central nervous system viral invasion and inflammation during acute HIV infection","volume":"206","author":"Valcour","year":"2012","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coviro.2019.06.004_bib0140","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1186\/s12974-014-0199-y","article-title":"Progressive increase in central nervous system immune activation in untreated primary HIV-1 infection","volume":"11","author":"Suh","year":"2014","journal-title":"J Neuroinflamm"},{"key":"10.1016\/j.coviro.2019.06.004_bib0145","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/s13365-011-0030-9","article-title":"Alterations in brain metabolism during the first year of HIV infection","volume":"17","author":"Lentz","year":"2011","journal-title":"J Neurovirol"},{"key":"10.1016\/j.coviro.2019.06.004_bib0150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0049272","article-title":"Change in brain magnetic resonance spectroscopy after treatment during acute HIV infection","volume":"7","author":"Sailasuta","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.coviro.2019.06.004_bib0155","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1212\/WNL.0000000000000932","article-title":"Cerebral metabolite changes prior to and after antiretroviral therapy in primary HIV infection","volume":"83","author":"Young","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.coviro.2019.06.004_bib0160","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1093\/cercor\/bhr285","article-title":"Regional cortical thinning associated with detectable levels of HIV DNA","volume":"22","author":"Kallianpur","year":"2012","journal-title":"Cereb Cortex"},{"key":"10.1016\/j.coviro.2019.06.004_bib0165","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/ana.410190602","article-title":"The AIDS dementia complex: I. Clinical features","volume":"19","author":"Navia","year":"1986","journal-title":"Ann Neurol"},{"key":"10.1016\/j.coviro.2019.06.004_bib0170","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/nrmicro3471","article-title":"Bottlenecks in HIV-1 transmission: insights from the study of founder viruses","volume":"13","author":"Joseph","year":"2015","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.coviro.2019.06.004_bib0175","doi-asserted-by":"crossref","first-page":"6277","DOI":"10.1128\/JVI.76.12.6277-6292.2002","article-title":"Increased CCR5 affinity and reduced CCR5\/CD4 dependence of a neurovirulent primary human immunodeficiency virus type 1 isolate","volume":"76","author":"Gorry","year":"2002","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2019.06.004_bib0180","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1128\/JVI.72.4.2855-2864.1998","article-title":"Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1","volume":"72","author":"Platt","year":"1998","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2019.06.004_bib0185","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.virol.2006.09.036","article-title":"Macrophage entry mediated by HIV Envs from brain and lymphoid tissues is determined by the capacity to use low CD4 levels and overall efficiency of fusion","volume":"360","author":"Thomas","year":"2007","journal-title":"Virology"},{"key":"10.1016\/j.coviro.2019.06.004_bib0190","doi-asserted-by":"crossref","first-page":"11294","DOI":"10.1128\/JVI.00946-15","article-title":"Phenotypic correlates of HIV-1 macrophage tropism","volume":"89","author":"Arrildt","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2019.06.004_bib0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004720","article-title":"Compartmentalized replication of R5 T cell-tropic HIV-1 in the central nervous system early in the course of infection","volume":"11","author":"Sturdevant","year":"2015","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2019.06.004_bib0200","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1128\/JVI.03333-13","article-title":"Epigenetic regulation of HIV-1 latency in astrocytes","volume":"88","author":"Narasipura","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2019.06.004_bib0205","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1128\/JVI.80.1.541-544.2006","article-title":"Gamma interferon primes productive human immunodeficiency virus infection in astrocytes","volume":"80","author":"Carroll-Anzinger","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2019.06.004_bib0210","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1093\/infdis\/jiy583","article-title":"Sex influences SAMHD1 activity and susceptibility to human immunodeficiency virus-1 in primary human macrophages","volume":"219","author":"Szaniawski","year":"2019","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coviro.2019.06.004_bib0215","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1007\/s11481-009-9174-2","article-title":"CNS inflammation and macrophage\/microglial biology associated with HIV-1 infection","volume":"4","author":"Yadav","year":"2009","journal-title":"J Neuroimmune Pharmacol"},{"key":"10.1016\/j.coviro.2019.06.004_bib0220","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.ncl.2008.04.002","article-title":"HIV infection of the central nervous system: clinical features and neuropathogenesis","volume":"26","author":"Boiss\u00e9","year":"2008","journal-title":"Neurol Clin"},{"key":"10.1016\/j.coviro.2019.06.004_bib0225","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1146\/annurev.neuro.25.112701.142822","article-title":"Central nervous system damage, monocytes and macrophages, and neurological disorders in AIDS","volume":"25","author":"Williams","year":"2002","journal-title":"Annu Rev Neurosci"},{"key":"10.1016\/j.coviro.2019.06.004_bib0230","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/ana.21697","article-title":"Extensive astrocyte infection is prominent in human immunodeficiency virus-associated dementia","volume":"66","author":"Churchill","year":"2009","journal-title":"Ann Neurol"},{"key":"10.1016\/j.coviro.2019.06.004_bib0235","doi-asserted-by":"crossref","first-page":"463","DOI":"10.2174\/1570162033485122","article-title":"Astrocyte infection by HIV-1: mechanisms of restricted virus replication, and role in the pathogenesis of HIV-1-associated dementia","volume":"1","author":"Gorry","year":"2003","journal-title":"Curr HIV Res"},{"key":"10.1016\/j.coviro.2019.06.004_bib0240","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1742-4690-7-30","article-title":"Molecular mechanisms of neuroinvasion by monocytes-macrophages in HIV-1 infection","volume":"7","author":"Gras","year":"2010","journal-title":"Retrovirology"},{"key":"10.1016\/j.coviro.2019.06.004_bib0245","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/ana.410340307","article-title":"Cerebral white matter changes in acquired immunodeficiency syndrome dementia: alterations of the blood-brain barrier","volume":"34","author":"Power","year":"1993","journal-title":"Ann Neurol"},{"key":"10.1016\/j.coviro.2019.06.004_bib0250","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004533","article-title":"Anti-\u03b14 antibody treatment blocks virus traffic to the brain and gut early, and stabilizes CNS injury late in infection","volume":"10","author":"Campbell","year":"2014","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2019.06.004_bib0255","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1038\/nm1511","article-title":"Microbial translocation is a cause of systemic immune activation in chronic HIV infection","volume":"12","author":"Brenchley","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/j.coviro.2019.06.004_bib0260","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0002516","article-title":"Microbial translocation is associated with increased monocyte activation and dementia in AIDS patients","volume":"3","author":"Ancuta","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.coviro.2019.06.004_bib0265","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0054673","article-title":"Brain microbial populations in HIV\/AIDS: \u03b1-proteobacteria predominate independent of host immune status","volume":"8","author":"Branton","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.coviro.2019.06.004_bib0270","doi-asserted-by":"crossref","DOI":"10.1038\/srep37344","article-title":"Brain microbiota disruption within inflammatory demyelinating lesions in multiple sclerosis","volume":"6","author":"Branton","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.coviro.2019.06.004_bib0275","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/ana.22344","article-title":"Gut, bugs, and brain: role of commensal bacteria in the control of central nervous system disease","volume":"69","author":"Ochoa-Rep\u00e1raz","year":"2011","journal-title":"Ann Neurol"},{"key":"10.1016\/j.coviro.2019.06.004_bib0280","doi-asserted-by":"crossref","first-page":"11016","DOI":"10.1128\/JVI.01242-09","article-title":"A quantitative affinity-profiling system that reveals distinct CD4\/CCR5 usage patterns among human immunodeficiency virus type 1 and simian immunodeficiency virus strains","volume":"83","author":"Johnston","year":"2009","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2019.06.004_bib0285","doi-asserted-by":"crossref","first-page":"10073","DOI":"10.1128\/JVI.75.21.10073-10089.2001","article-title":"Macrophage tropism of human immunodeficiency virus type 1 isolates from brain and lymphoid tissues predicts neurotropism independent of coreceptor specificity","volume":"75","author":"Gorry","year":"2001","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2019.06.004_bib0290","doi-asserted-by":"crossref","first-page":"6581","DOI":"10.4049\/jimmunol.178.10.6581","article-title":"The CD16+ monocyte subset is more permissive to infection and preferentially harbors HIV-1 in vivo","volume":"178","author":"Ellery","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.coviro.2019.06.004_bib0295","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1523\/JNEUROSCI.3863-05.2006","article-title":"CCL2\/monocyte chemoattractant protein-1 mediates enhanced transmigration of human immunodeficiency virus (HIV)-infected leukocytes across the blood-brain barrier: a potential mechanism of HIV-CNS invasion and NeuroAIDS","volume":"26","author":"Eugenin","year":"2006","journal-title":"J Neurosci"},{"key":"10.1016\/j.coviro.2019.06.004_bib0300","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1097\/QAD.0000000000002195","article-title":"HIV-1 is rarely detected in blood and colon myeloid cells during viral-suppressive antiretroviral therapy","volume":"33","author":"Cattin","year":"2019","journal-title":"AIDS"},{"key":"10.1016\/j.coviro.2019.06.004_bib0305","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1172\/JCI84456","article-title":"Macrophages sustain HIV replication in vivo independently of T cells","volume":"126","author":"Honeycutt","year":"2016","journal-title":"J Clin Invest"},{"key":"10.1016\/j.coviro.2019.06.004_bib0310","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/00005072-199507000-00003","article-title":"HIV infection of human choroid plexus: a possible mechanism of viral entry into the CNS","volume":"54","author":"Falangola","year":"1995","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.coviro.2019.06.004_bib0315","doi-asserted-by":"crossref","first-page":"498","DOI":"10.3109\/13550280009091950","article-title":"Comparisons of HIV-1 viral sequences in brain, choroid plexus and spleen: potential role of choroid plexus in the pathogenesis of HIV encephalitis","volume":"6","author":"Chen","year":"2000","journal-title":"J Neurovirol"},{"key":"10.1016\/j.coviro.2019.06.004_bib0320","doi-asserted-by":"crossref","first-page":"670","DOI":"10.3109\/13550289909021295","article-title":"HIV infection of choroid plexus in AIDS and asymptomatic HIV-infected patients suggests that the choroid plexus may be a reservoir of productive infection","volume":"5","author":"Petito","year":"1999","journal-title":"J Neurovirol"},{"key":"10.1016\/j.coviro.2019.06.004_bib0325","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1007\/s00109-017-1573-x","article-title":"Brain perivascular macrophages: characterization and functional roles in health and disease","volume":"95","author":"Faraco","year":"2017","journal-title":"J Mol Med (Berl)"},{"key":"10.1016\/j.coviro.2019.06.004_bib0330","doi-asserted-by":"crossref","first-page":"3703","DOI":"10.1523\/JNEUROSCI.5522-06.2007","article-title":"HIV-1 Vpr causes neuronal apoptosis and in vivo neurodegeneration","volume":"27","author":"Jones","year":"2007","journal-title":"J Neurosci"},{"key":"10.1016\/j.coviro.2019.06.004_bib0335","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.virol.2004.08.024","article-title":"Human immunodeficiency virus type 1 Nef protein mediates neural cell death: a neurotoxic role for IP-10","volume":"329","author":"van Marle","year":"2004","journal-title":"Virology"},{"key":"10.1016\/j.coviro.2019.06.004_bib0340","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/nature12940","article-title":"Cell death by pyroptosis drives CD4 T-cell depletion in HIV-1 infection","volume":"505","author":"Doitsh","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.coviro.2019.06.004_bib0345","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1742-4690-11-35","article-title":"Rapid inflammasome activation in microglia contributes to brain disease in HIV\/AIDS","volume":"11","author":"Walsh","year":"2014","journal-title":"Retrovirology"},{"key":"10.1016\/j.coviro.2019.06.004_bib0350","doi-asserted-by":"crossref","first-page":"8968","DOI":"10.1128\/JVI.00674-16","article-title":"HIV DNA is frequently present within pathologic tissues evaluated at autopsy from combined antiretroviral therapy-treated patients with undetectable viral loads","volume":"90","author":"Lamers","year":"2016","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2019.06.004_bib0355","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/BF00688301","article-title":"Multinucleated giant cells in brain: a hallmark of the acquired immune deficiency syndrome (AIDS)","volume":"69","author":"Budka","year":"1986","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.coviro.2019.06.004_bib0360","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/BF00687080","article-title":"Brain pathology induced by infection with the human immunodeficiency virus (HIV). A histological, immunocytochemical, and electron microscopical study of 100 autopsy cases","volume":"75","author":"Budka","year":"1987","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.coviro.2019.06.004_bib0365","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/09540260701862037","article-title":"The neuropathology of HIV\/AIDS","volume":"20","author":"Anthony","year":"2008","journal-title":"Int Rev Psychiatry"},{"key":"10.1016\/j.coviro.2019.06.004_bib0370","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2011.09.010","article-title":"Hiding in plain sight: how HIV evades innate immune responses","volume":"147","author":"Manel","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.coviro.2019.06.004_bib0375","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.cytogfr.2018.03.004","article-title":"Interferon-associated therapies toward HIV control: the back and forth","volume":"40","author":"No\u00ebl","year":"2018","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.coviro.2019.06.004_bib0380","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s11904-017-0357-9","article-title":"Mechanisms of HIV-1 control","volume":"14","author":"Soliman","year":"2017","journal-title":"Curr HIV\/AIDS Rep"},{"key":"10.1016\/j.coviro.2019.06.004_bib0385","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1038\/s41564-018-0256-x","article-title":"Primate immunodeficiency virus proteins Vpx and Vpr counteract transcriptional repression of proviruses by the HUSH complex","volume":"3","author":"Yurkovetskiy","year":"2018","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.coviro.2019.06.004_bib0390","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/s41564-018-0179-6","article-title":"HIV-2\/SIV viral protein X counteracts HUSH repressor complex","volume":"3","author":"Chougui","year":"2018","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.coviro.2019.06.004_bib0395","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1097\/QAD.0000000000001793","article-title":"Lentiviral infection of proliferating brain macrophages in HIV and simian immunodeficiency virus encephalitis despite sterile alpha motif and histidine-aspartate domain-containing protein 1 expression","volume":"32","author":"Lindgren","year":"2018","journal-title":"AIDS"},{"key":"10.1016\/j.coviro.2019.06.004_bib0400","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1096\/fj.13-227868","article-title":"Differential type 1 interferon-regulated gene expression in the brain during AIDS: interactions with viral diversity and neurovirulence","volume":"27","author":"Polyak","year":"2013","journal-title":"FASEB J"},{"key":"10.1016\/j.coviro.2019.06.004_bib0405","doi-asserted-by":"crossref","DOI":"10.3390\/v10030110","article-title":"Are microRNAs important players in HIV-1 infection? An update","volume":"10","author":"Balasubramaniam","year":"2018","journal-title":"Viruses"},{"key":"10.1016\/j.coviro.2019.06.004_bib0410","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.celrep.2017.09.030","article-title":"Host MicroRNAs-221 and -222 inhibit HIV-1 entry in macrophages by targeting the CD4 viral receptor","volume":"21","author":"Lodge","year":"2017","journal-title":"Cell Rep"},{"key":"10.1016\/j.coviro.2019.06.004_bib0415","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006360","article-title":"MicroRNAs upregulated during HIV infection target peroxisome biogenesis factors: implications for virus biology, disease mechanisms and neuropathology","volume":"13","author":"Xu","year":"2017","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2019.06.004_bib0420","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1007\/s11481-017-9730-0","article-title":"Tat-mediated induction of miRs-34a & -138 promotes astrocytic activation via downregulation of SIRT1: implications for aging in HAND","volume":"12","author":"Hu","year":"2017","journal-title":"J Neuroimmune Pharmacol"},{"key":"10.1016\/j.coviro.2019.06.004_bib0425","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1097\/QAD.0000000000001160","article-title":"Plasma microRNA profiling predicts HIV-associated neurocognitive disorder","volume":"30","author":"Asahchop","year":"2016","journal-title":"AIDS"},{"key":"10.1016\/j.coviro.2019.06.004_bib0430","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S2055-6640(20)30929-8","article-title":"The HIV cure research agenda: the role of mathematical modelling and cost-effectiveness analysis","volume":"1","author":"Freedberg","year":"2015","journal-title":"J Virus Erad"},{"key":"10.1016\/j.coviro.2019.06.004_bib0435","article-title":"HIV-1 RNA detected in the CNS after years of suppressive antiretroviral therapy can originate from a replicating CNS reservoir or clonally expanded cells","author":"Joseph","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.coviro.2019.06.004_bib0440","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1097\/QAD.0000000000002091","article-title":"Cerebrospinal fluid HIV-1 escape according to different thresholds and underlying comorbidities: is it time to assess the definitions?","volume":"33","author":"Trunfio","year":"2019","journal-title":"AIDS"},{"key":"10.1016\/j.coviro.2019.06.004_bib0445","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1007\/s13365-016-0448-1","article-title":"Discordant CSF\/plasma HIV-1 RNA in patients with unexplained low-level viraemia","volume":"22","author":"Nightingale","year":"2016","journal-title":"J Neurovirol"},{"key":"10.1016\/j.coviro.2019.06.004_bib0450","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/QAD.0000000000002074","article-title":"Cerebrospinal fluid viral escape in aviremic HIV-infected patients receiving antiretroviral therapy: prevalence, risk factors and neurocognitive effects","volume":"33","author":"P\u00e9rez-Valero","year":"2019","journal-title":"AIDS"},{"key":"10.1016\/j.coviro.2019.06.004_bib0455","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s13365-017-0530-3","article-title":"Modeling brain lentiviral infections during antiretroviral therapy in AIDS","volume":"23","author":"Roda","year":"2017","journal-title":"J Neurovirol"},{"key":"10.1016\/j.coviro.2019.06.004_bib0460","doi-asserted-by":"crossref","first-page":"293","DOI":"10.2174\/157016206777709410","article-title":"From mice to macaques\u2014animal models of HIV nervous system disease","volume":"4","author":"Zink","year":"2006","journal-title":"Curr HIV Res"},{"key":"10.1016\/j.coviro.2019.06.004_bib0465","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/s13365-017-0593-1","article-title":"Neurologic disease in feline immunodeficiency virus infection: disease mechanisms and therapeutic interventions for NeuroAIDS","volume":"24","author":"Power","year":"2018","journal-title":"J Neurovirol"},{"key":"10.1016\/j.coviro.2019.06.004_bib0470","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12977-017-0370-5","article-title":"Reduced antiretroviral drug efficacy and concentration in HIV-infected microglia contributes to viral persistence in brain","volume":"14","author":"Asahchop","year":"2017","journal-title":"Retrovirology"},{"key":"10.1016\/j.coviro.2019.06.004_bib0475","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1212\/WNL.0b013e31821670fb","article-title":"Efavirenz associated with cognitive disorders in otherwise asymptomatic HIV-infected patients","volume":"76","author":"Ciccarelli","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.coviro.2019.06.004_bib0480","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1097\/QAD.0000000000000951","article-title":"Maraviroc-intensified combined antiretroviral therapy improves cognition in virally suppressed HIV-associated neurocognitive disorder","volume":"30","author":"Gates","year":"2016","journal-title":"AIDS"},{"key":"10.1016\/j.coviro.2019.06.004_bib0485","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.cell.2019.01.044","article-title":"CCR5 is a therapeutic target for recovery after stroke and traumatic brain injury","volume":"176","author":"Joy","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.coviro.2019.06.004_bib0490","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s40262-015-0257-3","article-title":"Central nervous system penetration of antiretroviral drugs: pharmacokinetic, pharmacodynamic and pharmacogenomic considerations","volume":"54","author":"Decloedt","year":"2015","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.coviro.2019.06.004_bib0495","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1212\/WNL.0000000000000564","article-title":"Antiretroviral penetration into the CNS and incidence of AIDS-defining neurologic conditions","volume":"83","author":"Caniglia","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.coviro.2019.06.004_bib0500","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/COH.0000000000000110","article-title":"The brain and HAART: collaborative and combative connections","volume":"9","author":"Meeker","year":"2014","journal-title":"Curr Opin HIV AIDS"},{"key":"10.1016\/j.coviro.2019.06.004_bib0505","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/QAD.0000000000000955","article-title":"HIV protease inhibitors disrupt astrocytic glutamate transporter function and neurobehavioral performance","volume":"30","author":"Vivithanaporn","year":"2016","journal-title":"AIDS"},{"key":"10.1016\/j.coviro.2019.06.004_bib0510","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ejpb.2018.06.002","article-title":"Nanotechnology approaches to eradicating HIV reservoirs","volume":"138","author":"Cao","year":"2018","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.coviro.2019.06.004_bib0515","doi-asserted-by":"crossref","first-page":"5477","DOI":"10.2174\/1381612822666160726113001","article-title":"Solving the blood-brain barrier challenge for the effective treatment of HIV replication in the central nervous system","volume":"22","author":"Bertrand","year":"2016","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.coviro.2019.06.004_bib0520","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.biomaterials.2018.09.018","article-title":"Bioimaging predictors of rilpivirine biodistribution and antiretroviral activities","volume":"185","author":"Ottemann","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.coviro.2019.06.004_bib0525","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s11481-016-9716-3","article-title":"Nanoformulated antiretrovirals for penetration of the central nervous system: state of the art","volume":"12","author":"Fiandra","year":"2017","journal-title":"J Neuroimmune Pharmacol"},{"key":"10.1016\/j.coviro.2019.06.004_bib0530","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1056\/NEJMoa0802905","article-title":"Long-term control of HIV by CCR5 Delta32\/Delta32 stem-cell transplantation","volume":"360","author":"H\u00fctter","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coviro.2019.06.004_bib0535","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006753","article-title":"Long-term persistence and function of hematopoietic stem cell-derived chimeric antigen receptor T cells in a nonhuman primate model of HIV\/AIDS","volume":"13","author":"Zhen","year":"2017","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2019.06.004_bib0540","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1097\/COH.0000000000000485","article-title":"Chimeric antigen receptor T-cell approaches to HIV cure","volume":"13","author":"Kuhlmann","year":"2018","journal-title":"Curr Opin HIV AIDS"},{"key":"10.1016\/j.coviro.2019.06.004_bib0545","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/nature17642","article-title":"Corrigendum: viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117","volume":"535","author":"Caskey","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.coviro.2019.06.004_bib0550","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/nature18929","article-title":"HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption","volume":"535","author":"Scheid","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.coviro.2019.06.004_bib0555","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaf6517","article-title":"Latency reversal and viral clearance to cure HIV-1","volume":"353","author":"Margolis","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.coviro.2019.06.004_bib0560","doi-asserted-by":"crossref","first-page":"397","DOI":"10.3389\/fimmu.2016.00397","article-title":"Targeting the brain reservoirs: toward an HIV cure","volume":"7","author":"Marban","year":"2016","journal-title":"Front Immunol"},{"key":"10.1016\/j.coviro.2019.06.004_bib0565","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/QAD.0b013e3283437d2f","article-title":"Eradication of HIV from the brain: reasons for pause","volume":"25","author":"Nath","year":"2011","journal-title":"AIDS"},{"key":"10.1016\/j.coviro.2019.06.004_bib0570","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/QAD.0000000000001267","article-title":"Reactivation of simian immunodeficiency virus reservoirs in the brain of virally suppressed macaques","volume":"31","author":"Gama","year":"2017","journal-title":"AIDS"},{"key":"10.1016\/j.coviro.2019.06.004_bib0575","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1126\/science.1217550","article-title":"Natural SIV hosts: showing AIDS the door","volume":"335","author":"Chahroudi","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.coviro.2019.06.004_bib0580","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1126\/science.283.5403.857","article-title":"Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes","volume":"283","author":"Schmitz","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.coviro.2019.06.004_bib0585","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s11481-011-9330-3","article-title":"Monocyte mobilization, activation markers, and unique macrophage populations in the brain: observations from SIV infected monkeys are informative with regard to pathogenic mechanisms of HIV infection in humans","volume":"7","author":"Williams","year":"2012","journal-title":"J Neuroimmune Pharmacol"},{"key":"10.1016\/j.coviro.2019.06.004_bib0590","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1086\/653213","article-title":"Simian immunodeficiency virus-infected macaques treated with highly active antiretroviral therapy have reduced central nervous system viral replication and inflammation but persistence of viral DNA","volume":"202","author":"Zink","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coviro.2019.06.004_bib0595","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1080\/13550280802132824","article-title":"Virus-host interaction in the simian immunodeficiency virus-infected brain","volume":"14","author":"Fox","year":"2008","journal-title":"J Neurovirol"},{"key":"10.1016\/j.coviro.2019.06.004_bib0600","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1007\/s11481-011-9328-x","article-title":"Genetic knockouts suggest a critical role for HIV co-receptors in models of HIV gp120-induced brain injury","volume":"7","author":"Maung","year":"2012","journal-title":"J Neuroimmune Pharmacol"},{"key":"10.1016\/j.coviro.2019.06.004_bib0605","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/367188a0","article-title":"Central nervous system damage produced by expression of the HIV-1 coat protein gp120 in transgenic mice","volume":"367","author":"Toggas","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.coviro.2019.06.004_bib0610","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/s13365-017-0598-9","article-title":"Doxycycline-inducible and astrocyte-specific HIV-1 Tat transgenic mice (iTat) as an HIV\/neuroAIDS model","volume":"24","author":"Langford","year":"2018","journal-title":"J Neurovirol"},{"key":"10.1016\/j.coviro.2019.06.004_bib0615","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.bbi.2015.02.020","article-title":"The HIV-1 transgenic rat model of neuroHIV","volume":"48","author":"Vigorito","year":"2015","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.coviro.2019.06.004_bib0620","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1007\/s11481-011-9316-1","article-title":"Mice chronically infected with chimeric HIV resist peripheral and brain superinfection: a model of protective immunity to HIV","volume":"7","author":"Kelschenbach","year":"2012","journal-title":"J Neuroimmune Pharmacol"},{"key":"10.1016\/j.coviro.2019.06.004_bib0625","doi-asserted-by":"crossref","first-page":"3760","DOI":"10.1073\/pnas.0500649102","article-title":"A mouse model for study of systemic HIV-1 infection, antiviral immune responses, and neuroinvasiveness","volume":"102","author":"Potash","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2019.06.004_bib0630","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0306-4522(93)90278-N","article-title":"Neurotoxicity of peptide analogues of the transactivating protein tat from Maedi-Visna virus and human immunodeficiency virus","volume":"53","author":"Hayman","year":"1993","journal-title":"Neuroscience"},{"key":"10.1016\/j.coviro.2019.06.004_bib0635","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s11481-012-9355-2","article-title":"Rodent models of HAND and drug abuse: exogenous administration of viral protein(s) and cocaine","volume":"7","author":"Yao","year":"2012","journal-title":"J Neuroimmune Pharmacol"},{"key":"10.1016\/j.coviro.2019.06.004_bib0640","doi-asserted-by":"crossref","first-page":"3148","DOI":"10.1523\/JNEUROSCI.5473-10.2011","article-title":"Loss of neuronal integrity during progressive HIV-1 infection of humanized mice","volume":"31","author":"Dash","year":"2011","journal-title":"J Neurosci"},{"key":"10.1016\/j.coviro.2019.06.004_bib0645","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.2353\/ajpath.2010.100536","article-title":"Links between progressive HIV-1 infection of humanized mice and viral neuropathogenesis","volume":"177","author":"Gorantla","year":"2010","journal-title":"Am J Pathol"},{"key":"10.1016\/j.coviro.2019.06.004_bib0650","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/1742-4690-10-121","article-title":"HIV-1 infection, response to treatment and establishment of viral latency in a novel humanized T cell-only mouse (TOM) model","volume":"10","author":"Honeycutt","year":"2013","journal-title":"Retrovirology"},{"key":"10.1016\/j.coviro.2019.06.004_bib0655","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.1172\/JCI98968","article-title":"T cells establish and maintain CNS viral infection in HIV-infected humanized mice","volume":"128","author":"Honeycutt","year":"2018","journal-title":"J Clin Invest"},{"key":"10.1016\/j.coviro.2019.06.004_bib0660","first-page":"658","article-title":"Feline immunodeficiency virus: a neurotropic lentivirus","volume":"3","author":"Dow","year":"1990","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.coviro.2019.06.004_bib0665","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1007\/s11481-011-9325-0","article-title":"Suppression of immunodeficiency virus-associated neural damage by the p75 neurotrophin receptor ligand, LM11A-31, in an in vitro feline model","volume":"7","author":"Meeker","year":"2012","journal-title":"J Neuroimmune Pharmacol"}],"container-title":["Current Opinion in Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879625719300471?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879625719300471?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T21:20:19Z","timestamp":1783632019000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879625719300471"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":133,"alternative-id":["S1879625719300471"],"URL":"https:\/\/doi.org\/10.1016\/j.coviro.2019.06.004","relation":{},"ISSN":["1879-6257"],"issn-type":[{"value":"1879-6257","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HIV-1 persistence in the central nervous system: viral and host determinants during antiretroviral therapy","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coviro.2019.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2019 Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}